FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33051000077117 deux fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    deux Is a General adjectival modifier false Inferred relationship Some
    deux Is a nombre false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Codeine phosphate 30 mg and paracetamol 300 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Aspirin 325 mg and methocarbamol 400 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Aspirin 81 mg and pravastatin 20 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Codeine phosphate 30 mg and paracetamol 500 mg oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Aspirin 81 mg and pravastatin 40 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Dihydrocodeine tartrate 20 mg and paracetamol 500 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Aspirin 81 mg and pravastatin 80 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Butalbital 50 mg and paracetamol 325 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely desogestrel 125 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Aspirin 325 mg and pravastatin 80 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Aspirin 325 mg and pravastatin 40 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Atenolol 100 mg and chlortalidone 25 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine 5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Diclofenac sodium 75 mg and misoprostol 200 microgram oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Atenolol 50 mg and chlortalidone 25 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Chlorothiazide 250 mg and methyldopa 250 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Chlorothiazide 250 mg and reserpine 125 microgram oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine 10 milligram and telmisartan 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Atenolol 50 mg and chlortalidone 12.5 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Desogestrel 150 microgram and ethinylestradiol 20 microgram oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely ampicillin 250 milligram and flucloxacillin 250 milligram/1 each conventional release oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Amoxicillin 800 mg and clavulanate potassium 125 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely caffeine 65 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Benazepril hydrochloride 5 mg and hydrochlorothiazide 6.25 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Choline bitartrate 25 mg and dexpanthenol 50 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amitriptyline 25 milligram and perphenazine 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amitriptyline 10 milligram and perphenazine 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Caffeine 25 mg and paracetamol 450 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amitriptyline 25 milligram and perphenazine 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amitriptyline 50 milligram and perphenazine 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Codeine phosphate 20 mg and ibuprofen 300 mg prolonged-release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Amobarbital sodium 100 mg and secobarbital sodium 100 mg oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Butalbital 50 mg and paracetamol 650 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some

    Start Page 2 of 24 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start